Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj S

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Nature Communications|April 2, 2021
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Cureus|November 25, 2022
Competence-Based Assessment of Biomedical Equipment Management and Maintenance System (e-Upkaran) Using Benefit Evaluation FrameworkPankaj Bhardwaj, Nitin K Joshi, Prem Singh, et al.
Molecules (Basel, Switzerland)|January 21, 2023
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR InhibitorsM Akiful Haque, Akash Marathakam, Ritesh Rana, et al.
Cell Reports|November 3, 2021
An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infectionXiaohua Duan, Xuming Tang, Manoj S Nair, et al.
RSC Advances|August 16, 2023
A novel series of dipeptide derivatives containing indole-3-carboxylic acid conjugates as potential antimicrobial agents: the design, solid phase peptide synthesis, <i>in vitro</i> biological evaluation, and molecular docking studySunil R Tivari, Siddhant V Kokate, Enrique Delgado-Alvarado, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.
Iscience|March 17, 2023
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boostManoj S Nair, Ruy M Ribeiro, Maple Wang, et al.
ACS Omega|January 1, 2024
Synthesis and Evaluation of Biological Activities for a Novel 1,2,3,4-Tetrahydroisoquinoline Conjugate with Dipeptide Derivatives: Insights from Molecular Docking and Molecular Dynamics SimulationsSunil R Tivari, Siddhant V Kokate, José L Belmonte-Vázquez, et al.
Cell Reports|October 27, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Nature Communications|April 2, 2021
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.
Cureus|November 25, 2022
Competence-Based Assessment of Biomedical Equipment Management and Maintenance System (e-Upkaran) Using Benefit Evaluation FrameworkPankaj Bhardwaj, Nitin K Joshi, Prem Singh, et al.
Molecules (Basel, Switzerland)|January 21, 2023
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR InhibitorsM Akiful Haque, Akash Marathakam, Ritesh Rana, et al.
Cell Reports|November 3, 2021
An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infectionXiaohua Duan, Xuming Tang, Manoj S Nair, et al.
RSC Advances|August 16, 2023
A novel series of dipeptide derivatives containing indole-3-carboxylic acid conjugates as potential antimicrobial agents: the design, solid phase peptide synthesis, <i>in vitro</i> biological evaluation, and molecular docking studySunil R Tivari, Siddhant V Kokate, Enrique Delgado-Alvarado, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.
Iscience|March 17, 2023
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boostManoj S Nair, Ruy M Ribeiro, Maple Wang, et al.
ACS Omega|January 1, 2024
Synthesis and Evaluation of Biological Activities for a Novel 1,2,3,4-Tetrahydroisoquinoline Conjugate with Dipeptide Derivatives: Insights from Molecular Docking and Molecular Dynamics SimulationsSunil R Tivari, Siddhant V Kokate, José L Belmonte-Vázquez, et al.
Cell Reports|October 27, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.
Pageof 14